Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of IV administration of
VX15/2503 in patients with advanced solid tumors. The escalation part of the study will
determine the maximum tolerated dose (MTD).